OcciGuide enables all practitioners to provide targeted, fast, lasting pain relief from headache and migraine, without systematic side effects. The device, which guides occipital nerve blocks, is registered with the FDA and was developed and tested at a top 20 medical center. Injections with OcciGuide have been shown to provide better pain relief than traditional treatment methods and to improve throughput in the emergency department.

  • Ezekiel Fink, MD
    Chief Medical Officer
  • Jillian Levovitz
    Chief Executive Officer
[ Feedback → ]